Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
7.35 USD +3.52% Intraday chart for EDAP TMS S.A. -2.52% +39.20%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading MT
Transcript : EDAP TMS S.A., Q4 2023 Earnings Call, Mar 27, 2024
EDAP TMS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
EDAP TMS S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading MT
EDAP TMS SA Announces FDA Breakthrough Device Designation for Focal One in the Treatment of Deep Infiltrating Rectal Endometriosis CI
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading MT
European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading But End Week Higher MT
EDAP TMS S.A. Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One Hifu Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis CI
European Equities Traded in the US as American Depositary Receipts Trend Lower in Monday Trading MT
EDAP Names Ken Mobeck Global Finance Chief MT
EDAP TMS S.A. Appoints Ken Mobeck as Chief Financial Officer CI
EDAP TMS S.A. Appoints Francois Dietsch as Global Chief Accounting Officer CI
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday But Likely to End Week Lower MT
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading MT
Chart EDAP TMS S.A.
More charts
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.35 USD
Average target price
12.33 USD
Spread / Average Target
+67.80%
Consensus
  1. Stock
  2. Equities
  3. Stock EDAP TMS S.A. - Nasdaq
  4. News EDAP TMS S.A.
  5. European ADRs Move Higher in Thursday Trading